Cargando…
OUTCOMES AND IMPACT OF COVID-19 ON INFECTION DIAGNOSIS RATES AMONG PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES
INTRODUCTION: We compared healthcare resource utilization (HCRU) among patients with primary immunodeficiency diseases (PIDD) in the United States before and after treatment initiation with immunoglobulin replacement therapy. Impact of COVID-19 mitigation efforts on infection diagnosis rates was eva...
Autores principales: | Riaz, F., Umashankar, K., Marchlewicz, E., Zhang, K., Sanchirico, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646422/ http://dx.doi.org/10.1016/j.anai.2022.08.646 |
Ejemplares similares
-
Practical challenges for functional validation of STAT1 gain of function genetic variants
por: Albuquerque, Adriana S, et al.
Publicado: (2023) -
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency
por: Milardi, Giulia, et al.
Publicado: (2022) -
Economic consequences for Medicaid of human immunodeficiency virus infection
por: Baily, Mary Ann, et al.
Publicado: (1990) -
D020 ROLE OF CELLULAR CASPASES AND THERAPEUTIC POTENTIAL OF A PAN-CASPASE INHIBITOR, EMRICASAN, IN COVID-19.
por: Alpan, O., et al.
Publicado: (2021) -
Aberrant cell signalling in PBMCs upon IFN‐α stimulation in primary Sjögren's syndrome patients associates with type I interferon signature
por: Davies, Richard, et al.
Publicado: (2018)